Effects of Nigella sativa on outcome of hepatitis C in Egypt

World Journal of Gastroenterology

Volumn 19, Issue 16, 2013, Pages 2529-2536

  Barakat, Eman Mahmoud Fathy ^a   El Wakeel, Lamia Mohamed ^b   Hagag, Radwa Samir ^c  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Ain Shams University   (Egypt)

^c EGYPTIAN RUSSIAN UNIVERSITY   (Egypt)

Author keywords

Hepatitis C virus; Nigella sativa; Oxidative stress; Viral load

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; GLUCOSE; NIGELLA SATIVA EXTRACT; PROTEIN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CELL COUNT; CHILD PUGH SCORE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPIGASTRIC PAIN; FEMALE; HEPATITIS C; HUMAN; HYPOGLYCEMIA; KIDNEY FUNCTION; LIVER FUNCTION; MALE; PERIPHERAL EDEMA; PILOT STUDY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PROTHROMBIN TIME; TREATMENT RESPONSE; VIRUS LOAD;

EID: 84877280196     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i16.2529     Document Type: Article

References (60)

1. Nguyen MH, Keeffe EB. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol 2005; 3: S97-S101 [PMID: 16234071]
2. Abdel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Thomas D, Fix AD, Strickland GT, Anwar W, Sallam I. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000; 32: 111-115 [PMID: 10869297 DOI: 10.1053/jhep.2000.8438]
3. Elkady A, Tanaka Y, Kurbanov F, Sugauchi F, Sugiyama M, Khan A, Sayed D, Mostafa G, Abdel-Hameed AR, Mizokami M. Genetic variability of hepatitis C virus in South Egypt and its possible clinical implication. J Med Virol 2009; 81: 1015-1023 [PMID: 19382263 DOI: 10.1002/jmv.21492]
4. Khattab MA, Ferenci P, Hadziyannis SJ, Colombo M, Manns MP, Almasio PL, Esteban R, Abdo AA, Harrison SA, Ibrahim N, Cacoub P, Eslam M, Lee SS. Management of hepatitis C virus genotype 4: recommendations of an international expert panel. J Hepatol 2011; 54: 1250-1262 [PMID: 21316497 DOI: 10.1016/j.jhep.2010.11.016]
5. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3: 47-52 [PMID: 16614742]
6. Pisani P, Parkin DM, Muñoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997; 6: 387-400 [PMID: 9184771]
7. Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res 2008; 659: 176-184 [PMID: 18346933 DOI: 10.1016/ j.mrrev.2008.01.005]
8. Lisker-Melman M, Sayuk GS. Defining optimal therapeutic outcomes in chronic hepatitis. Arch Med Res 2007; 38: 652-660 [PMID: 17613357 DOI: 10.1016/j.arcmed.2006.10.017]
9. El-Zayadi AR, Attia M, Barakat EM, Badran HM, Hamdy H, El-Tawil A, El-Nakeeb A, Selim O, Saied A. Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peginterferon-alpha2b/ribavirin or induction-dose interferonalpha2b/ribavirin/amantadine: a non-randomized controlled study. Am J Gastroenterol 2005; 100: 2447-2452 [PMID: 16279899 DOI: 10.1111/j.1572-0241.2005.00253.x]
10. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250 [PMID: 10644669]
11. Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 1997; 22: 287-305 [PMID: 8958154]
12. Abalea V, Cillard J, Dubos MP, Anger JP, Cillard P, Morel I. Iron-induced oxidative DNA damage and its repair in primary rat hepatocyte culture. Carcinogenesis 1998; 19: 1053-1059 [PMID: 9667744]
13. Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs 2001; 61: 2035-2063 [PMID: 11735632]
14. Zaher KS, Ahmed WM, Zerizer SN. Observations on the Biological Effects of Black Cumin Seed (Nigella sativa) and Green Tea (Camellia sinensis). Global Veterinaria 2008; 2: 198-204
15. Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res 2000; 14: 323-328 [PMID: 10925395]
16. Ramadan MF, Kroh LW, Mörsel JT. Radical scavenging activity of black cumin (Nigella sativa L.), coriander (Coriandrum sativum L.), and niger (Guizotia abyssinica Cass.) crude seed oils and oil fractions. J Agric Food Chem 2003; 51: 6961-6969 [PMID: 14611155 DOI: 10.1021/jf0346713]
17. Swamy SM, Tan BK. Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativa L. seeds. J Ethnopharmacol 2000; 70: 1-7 [PMID: 10720783]
18. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003; 17: 299-305 [PMID: 12722128 DOI: 10.1002/ptr.1309]
19. Al-Naggar TB, Gómez-Serranillos MP, Carretero ME, Villar AM. Neuropharmacological activity of Nigella sativa L. extracts. J Ethnopharmacol 2003; 88: 63-68 [PMID: 12902052]
20. Salem ML, Hossain MS. In vivo acute depletion of CD8(+) T cells before murine cytomegalovirus infection upregulated innate antiviral activity of natural killer cells. Int J Immunopharmacol 2000; 22: 707-718 [PMID: 10884591]
21. Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 2005; 5: 1749-1770 [PMID: 16275613 DOI: 10.1016/j.intimp.2005.06.008]
22. Meral I, Kanter M. Effects of Nigella sativa L. and Urtica dioica L. on selected mineral status and hematological values in CCl4-treated rats. Biol Trace Elem Res 2003; 96: 263-270 [PMID: 14716106]
23. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55: 245-264 [PMID: 21371579]
24. Ciccone E, Viale O, Pende D, Malnati M, Biassoni R, Melioli G, Moretta A, Long EO, Moretta L. Specific lysis of allogeneic cells after activation of CD3-lymphocytes in mixed lymphocyte culture. J Exp Med 1988; 168: 2403-2408 [PMID: 2974067]
25. Nelson DR. The immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 2001; 5: 931-953 [PMID: 11685802]
26. Joyce MA, Tyrrell DL. The cell biology of hepatitis C vi-rus. Microbes Infect 2010; 12: 263-271 [PMID: 20080204 DOI: 10.1016/j.micinf.2009.12.012]
27. Yildiz F, Coban S, Terzi A, Ates M, Aksoy N, Cakir H, Ocak AR, Bitiren M. Nigella sativa relieves the deleterious effects of ischemia reperfusion injury on liver. World J Gastroenterol 2008; 14: 5204-5209 [PMID: 18777598]
28. Enomoto S, Asano R, Iwahori Y, Narui T, Okada Y, Singab AN, Okuyama T. Hematological studies on black cumin oil from the seeds of Nigella sativa L. Biol Pharm Bull 2001; 24: 307-310 [PMID: 11256491]
29. Muting D, Wohlgemuth D, Dorsett R. Liver cirrhosis and diabetes mellitus. Geriatrics 1969; 24: 91-99 [PMID: 5782543]
30. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313: 1256-1262 [PMID: 4058506 DOI: 10.1056/nejm198511143132004]
31. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-333 [PMID: 9918906 DOI: 10.1002/ hep.510290235]
32. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-1139 [PMID: 7699240]
33. Fraser GM, Harman I, Meller N, Niv Y, Porath A. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci 1996; 32: 526-530 [PMID: 8756978]
34. Grimbert S, Valensi P, Lévy-Marchal C, Perret G, Richardet JP, Raffoux C, Trinchet JC, Beaugrand M. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol 1996; 20: 544-548 [PMID: 8881566]
35. Ozyilkan E, Arslan M. Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1996; 91: 1480-1481 [PMID: 8678039]
36. Kawaguchi T, Sata M. Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization. World J Gastroenterol 2010; 16: 1943-1952 [PMID: 20419831]
37. Bamosa AO, Kaatabi H, Lebdaa FM, Elq AM, Al-Sultanb A. Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian J Physiol Pharmacol 2010; 54: 344-354 [PMID: 21675032]
38. Srinivasan R. Autoimmune hemolytic anemia in treatmentnaïve chronic hepatitis C infection. J Clin Gastroenterol 2001; 32: 245-247 [PMID: 11246355]
39. Chao TC, Chen CY, Yang YH, Chen PM, Chang FY, Lee SD. Chronic hepatitis C virus infection associated with primary warm-type autoimmune hemolytic anemia. J Clin Gastroenterol 2001; 33: 232-233 [PMID: 11500615]
40. Moccia F, Tognoni E, Boccaccio P. Autoimmune hemolytic anemia in chronic hepatitis C virus infection: an unusual extrahepatic autoimmune manifestation. Ann Ital Med Int 2001; 16: 256-259 [PMID: 11799634]
41. Spivak JL. The blood in systemic disorders. Lancet 2000; 355: 1707-1712 [PMID: 10905258 DOI: 10.1016/s0140-6736(00) 02249-2]
42. Streiff MB, Mehta S, Thomas DL. Peripheral blood count abnormalities among patients with hepatitis C in the United States. Hepatology 2002; 35: 947-952 [PMID: 11915043 DOI: 10.1053/jhep.2002.32486]
43. Dieterich DT, Spivak JL. Hematologic disorders associated with hepatitis C virus infection and their management. Clin Infect Dis 2003; 37: 533-541 [PMID: 12905138 DOI: 10.1086/ 376971]
44. Meral I, Donmez N, Baydas B, Belge F, Kanter M. Effect of Nigella sativa L. on heart rate and some haematological values of alloxan-induced diabetic rabbits. Scand J Lab Anim Sci 2004; 31: 49-53
45. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004; 17: 432-437 [PMID: 15660573 DOI: 10.1111/j.0894-0959.2004.17603.x]
46. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005; 41: 1211-1219 [PMID: 15915465 DOI: 10.1002/hep.20720]
47. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-333 [PMID: 9918906 DOI: 10.1002/ hep.510290235]
48. Nagao Y, Sata M. Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan. Virol J 2010; 7: 375 [PMID: 21194423 DOI: 10.1186/1743-422x-7-375]
49. Kotoh K, Nakamuta M, Fukushima M, Matsuzaki C, Enjoji M, Sakai H, Nawata H. High relative fat-free mass is important for maintaining serum albumin levels in patients with compensated liver cirrhosis. World J Gastroenterol 2005; 11: 1356-1360 [PMID: 15761975]
50. Khan MH, Farrell GC, Byth K, Lin R, Weltman M, George J, Samarasinghe D, Kench J, Kaba S, Crewe E, Liddle C. Which patients with hepatitis C develop liver complications? Hepatology 2000; 31: 513-520 [PMID: 10655279]
51. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997; 50: 693-703 [PMID: 9250267]
52. Corti MC, Salive ME, Guralnik JM. Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol 1996; 49: 519-526 [PMID: 8636725]
53. al-Gaby AM. Amino acid composition and biological effects of supplementing broad bean and corn proteins with Nigella sativa (black cumin) cake protein. Nahrung 1998; 42: 290-294 [PMID: 9882224]
54. Tollbaand AAH, Hassan MSH. Using some natural additives to improve physiological and productive performance of broiler chicks under high temperature conditions 2 -black cumin (Nigella Sativa) or garlic (Allium sativum). Egypt Poul Sci 2003; 23: 327-340
55. Shewita RS, Taha AE. Effect of Dietary Supplementation of Different Levels of Black Seed (Nigella Sativa L.) on Growth Performance, Immunological, Hematological and Carcass Parameters of Broiler Chicks. WASET 2011; 77: 788-794
56. Zaoui A, Cherrah Y, Lacaille-Dubois MA, Settaf A, Amarouch H, Hassar M. [Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat]. Therapie 2000; 55: 379-382 [PMID: 10967716]
57. Sayed-Ahmed MM, Nagi MN. Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats. Clin Exp Pharmacol Physiol 2007; 34: 399-405 [PMID: 17439407 DOI: 10.1111/j.1440-1681.2007.04560. x]
58. Akhtar MS, Riffat S. Field trial of Saussurea lappa roots against nematodes and Nigella sativa seeds against cestodes in children. J Pak Med Assoc 1991; 41: 185-187 [PMID: 1942479]
59. Boskabady MH, Farhadi J. The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med 2008; 14: 1137-1144 [PMID: 18991514 DOI: 10.1089/acm.2008.0049]
60. Najmi A, Nasiruddin M, Khan RA, Haque SF. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. Int J Diabetes Dev Ctries 2008; 28: 11-14 [PMID: 19902033 DOI: 10.4103/0973-3930.41980]